BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15915305)

  • 1. [Oncolytic viral therapy of gliomas: review of the literature].
    Arrese I; González P; Miranda P; Pérez-Núñez A; Pascual B; Lobato RD
    Neurocirugia (Astur); 2005 Apr; 16(2):158-68. PubMed ID: 15915305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of viral therapy for malignant gliomas.
    Piccioni DE; Kesari S
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1297-305. PubMed ID: 24138481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for high-grade glioma.
    Iwami K; Natsume A; Wakabayashi T
    Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research.
    Lou E
    Ann Med; 2004; 36(1):2-8. PubMed ID: 15000342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.
    Zemp FJ; Corredor JC; Lun X; Muruve DA; Forsyth PA
    Cytokine Growth Factor Rev; 2010; 21(2-3):103-17. PubMed ID: 20483653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapies for malignant gliomas: a local affair?
    Rainov NG; Söling A; Heidecke V
    Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
    Shah AC; Benos D; Gillespie GY; Markert JM
    J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncolytic viruses in the therapy of gliomas].
    Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental therapies: gene therapies and oncolytic viruses.
    Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
    Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of experimental virus-mediated gene therapy for malignant glioma.
    Rainov NG; Heidecke V
    Anticancer Agents Med Chem; 2011 Oct; 11(8):739-47. PubMed ID: 21707496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene Therapy and Viral Therapy for Malignant Glioma].
    Kurozumi K; Koizumi S; Otani Y
    No Shinkei Geka; 2021 May; 49(3):608-616. PubMed ID: 34092566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of advances in molecular biology to the treatment of brain tumors.
    Takeshima H; Sawamura Y; Gilbert MR; Van Meir EG
    Curr Oncol Rep; 2000 Sep; 2(5):425-33. PubMed ID: 11122874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic HSV-1 for the treatment of brain tumours.
    Markert JM; Parker JN; Buchsbaum DJ; Grizzle WE; Gillespie GY; Whitley RJ
    Herpes; 2006 Nov; 13(3):66-71. PubMed ID: 17147910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting in gene therapy for gliomas.
    Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
    Arch Neurol; 1999 Apr; 56(4):445-8. PubMed ID: 10199333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.
    Zhang Q; Liu F
    Cell Death Dis; 2020 Jun; 11(6):485. PubMed ID: 32587256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic viral therapy of malignant glioma.
    Parker JN; Bauer DF; Cody JJ; Markert JM
    Neurotherapeutics; 2009 Jul; 6(3):558-69. PubMed ID: 19560745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditionally replicative adenoviral vectors for malignant glioma.
    Sonabend AM; Ulasov IV; Lesniak MS
    Rev Med Virol; 2006; 16(2):99-115. PubMed ID: 16416455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viruses for treatment of malignant brain tumours.
    Rainov NG; Ren H
    Acta Neurochir Suppl; 2003; 88():113-23. PubMed ID: 14531569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene- and viral-based therapies for brain tumors.
    Asadi-Moghaddam K; Chiocca EA
    Neurotherapeutics; 2009 Jul; 6(3):547-57. PubMed ID: 19560744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.